D. Voliotis
Impact in
- Hepatology top 0.1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Pathology and Forensic Medicine top 0.5%
- Cancer Mechanisms and Therapy
Papers in
- Hepatology 22
- Hepatocellular Carcinoma Treatment and Prognosis 21
-
- Melanoma and MAPK Pathways 6
- Co-authors
- Ann‐Lii Cheng (8 shared papers)Yoon‐Koo Kang (3 shared papers)Won Young Tak (5 shared papers)Tsai‐Sheng Yang (2 shared papers)Zhendong Chen (2 shared papers)Zhongzhen Guan (2 shared papers)Jianming Xu (2 shared papers)Chao-Jung Tsao (2 shared papers)
- Journals
- Journal of Clinical Oncology (19 papers)Journal of Hepatology (5 papers)Annals of Oncology (4 papers)European Journal of Cancer (3 papers)Cancer Research (2 papers)
- Partner nations
- GermanyUnited StatesTaiwan
In The Last Decade
D. Voliotis
48 papers receiving 7.5k citations
D. Voliotis's Hit Papers
Peers
Comparison fields: 5 of 101
- Hepatology 4.2k
- Pathology and Forensic Medicine 1.2k
- Cancer Research 1.0k
- Oncology 1.4k
- Epidemiology 1.2k
Countries citing papers authored by D. Voliotis
This map shows the geographic impact of D. Voliotis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Voliotis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Voliotis more than expected).
Fields of papers citing papers by D. Voliotis
This network shows the impact of papers produced by D. Voliotis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Voliotis. The network helps show where D. Voliotis may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Voliotis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2008 | 4666 |
| 2 | Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors Hit paper breakdown → | 2004 | 698 |
| 3 | Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial Hit paper breakdown → | 2012 | 661 |
| 4 | 2005 | 325 | |
| 5 | 2012 | 223 | |
| 6 | 2007 | 163 | |
| 7 | 2006 | 115 | |
| 8 | 2012 | 102 | |
| 9 | 2002 | 92 | |
| 10 | 2006 | 87 | |
| 11 | Safety and Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma (HCC) and Child-Pugh A versus B Cirrhosis. | 2011 | 79 |
| 12 | 2008 | 45 | |
| 13 | 2007 | 44 | |
| 14 | 2005 | 38 | |
| 15 | 2007 | 24 | |
| 16 | 2010 | 22 | |
| 17 | 2004 | 21 | |
| 18 | 2003 | 21 | |
| 19 | 2021 | 20 | |
| 20 | 2008 | 20 |
About D. Voliotis
D. Voliotis is a scholar working on Hepatology, Molecular Biology, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 49 papers that have together received 7.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (21 papers), Cancer, Lipids, and Metabolism (8 papers), Colorectal Cancer Treatments and Studies (7 papers), Lung Cancer Treatments and Mutations (7 papers), Melanoma and MAPK Pathways (6 papers), Cancer Mechanisms and Therapy (5 papers), Cancer Treatment and Pharmacology (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). The work is most often cited by research in Hepatology (4.2k citations), Pathology and Forensic Medicine (1.2k citations), Cancer Research (1.0k citations), Oncology (1.4k citations) and Epidemiology (1.2k citations). D. Voliotis has collaborated with scholars based in Germany, United States and Taiwan. Frequent co-authors include Ann‐Lii Cheng, Yoon‐Koo Kang, Won Young Tak, Tsai‐Sheng Yang, Zhendong Chen, Zhongzhen Guan, Jianming Xu, Chao-Jung Tsao, Hongming Pan and Jun Suk Kim. Their work appears in journals such as Journal of Clinical Oncology, Journal of Hepatology, Annals of Oncology, European Journal of Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.